Parisa Mashayekhi

ORCID: 0000-0002-6373-3266 · 3 papers in corpus
lab-animal 2022
Metformin as a potential agent for modulating the faulty endometriotic mesenchymal stem cells: A case-control study
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v20i10.12270

BACKGROUND: According to stem cell theory, it seems that the proliferation/differentiation imbalance in endometrial mesenchymal stem cells (enMSCs) is the leading cause of endometriosis, so targeting them to modulate stemness-relevant facto…

lab-animal 2020
Deregulation of Stemness-Related Genes in Endometriotic Mesenchymal Stem Cells: Further Evidence for Self-Renewal/Differentiation Imbalance
Iranian biomedical journal ·doi:10.29252/ibj.24.5.328

BACKGROUND: Any irregularities in self-renewal/differentiation balance in endometriotic mesenchymal stem cells (MSCs) can change their fate and function, resulting in endometriosis development. This study aimed to evaluate the expression of…

lab-animal 2019
Endometriotic Mesenchymal Stem Cells Epigenetic Pathogenesis: Deregulation of miR-200b, miR-145, and let7b in A Functional Imbalanced Epigenetic Disease
Cell journal ·doi:10.22074/cellj.2019.5903

OBJECTIVE: Stem cell issue is a strong theory in endometriosis pathogenesis. It seems that endometriotic mesenchymal stem cells (MSCs) show different characteristics compared to the normal MSCs. Determined high proliferation and low differe…